Your browser doesn't support javascript.
loading
Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel Disease.
Lim, Ki Jung; Lee, So Jung; Kim, Sunghwan; Lee, Su Yeon; Lee, Min Seob; Park, Yoon A; Choi, Eun Jin; Lee, Eun Beom; Jun, Hwang Keun; Cho, Jong Moon; Lee, SooYoung; Kwon, Ki Sung; Lim, Byung Pil; Jeon, Myung-Shin; Shin, Eui Cheol; Choi, Yong Sung; Fudim, Ella; Picard, Orit; Yavzori, Miri; Ben-Horin, Shomron; Chang, Shin Jae.
Afiliação
  • Lim KJ; R&D Division, Celltrion Inc., Incheon, Korea.
  • Lee SJ; R&D Division, Celltrion Inc., Incheon, Korea.
  • Kim S; R&D Division, Celltrion Inc., Incheon, Korea.
  • Lee SY; R&D Division, Celltrion Inc., Incheon, Korea.
  • Lee MS; R&D Division, Celltrion Inc., Incheon, Korea.
  • Park YA; R&D Division, Celltrion Inc., Incheon, Korea.
  • Choi EJ; R&D Division, Celltrion Inc., Incheon, Korea.
  • Lee EB; R&D Division, Celltrion Inc., Incheon, Korea.
  • Jun HK; R&D Division, Celltrion Inc., Incheon, Korea.
  • Cho JM; R&D Division, Celltrion Inc., Incheon, Korea.
  • Lee S; R&D Division, Celltrion Inc., Incheon, Korea.
  • Kwon KS; R&D Division, Celltrion Inc., Incheon, Korea.
  • Lim BP; R&D Division, Celltrion Inc., Incheon, Korea.
  • Jeon MS; Translational Research Center and Inha Research Institute for Medical Sciences, Inha University School of Medicine, Incheon, Korea.
  • Shin EC; Laboratory of Immunology and Infectious Disease, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea.
  • Choi YS; Department of Gastroenterology, Daehang Hospital, Seoul, Korea.
  • Fudim E; Department of Gastroenterology, Sheba Medical Center & Sackler School of Medicine, Tel-Aviv University, Ramat-Gan, Israel.
  • Picard O; Department of Gastroenterology, Sheba Medical Center & Sackler School of Medicine, Tel-Aviv University, Ramat-Gan, Israel.
  • Yavzori M; Department of Gastroenterology, Sheba Medical Center & Sackler School of Medicine, Tel-Aviv University, Ramat-Gan, Israel.
  • Ben-Horin S; Department of Gastroenterology, Sheba Medical Center & Sackler School of Medicine, Tel-Aviv University, Ramat-Gan, Israel.
  • Chang SJ; R&D Division, Celltrion Inc., Incheon, Korea.
J Crohns Colitis ; 11(5): 593-602, 2017 May 01.
Article em En | MEDLINE | ID: mdl-28453766
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Medicamentos Biossimilares / Infliximab / Intestinos / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: J Crohns Colitis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Medicamentos Biossimilares / Infliximab / Intestinos / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: J Crohns Colitis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2017 Tipo de documento: Article